stockrowCelcuity, Inc.
CELC Healthcare Biotechnology
- EPS
- −38.5%
- Free cash flow
- −53.3%
- Total debt
- +658.7%
Quarter to June 2026, against a year earlier
Follow CELC
Alert me
Celcuity, Inc. (CELC) Free cash flow
Celcuity, Inc.'s free cash flow for fiscal 2025 was −$153.5M, compared with −$83.7M in fiscal 2024. Over the twelve months to 30 June 2026 it was −$192.3M. Over the past ten years it has ranged from −$153.5M (fiscal 2025) to −$2.1M (fiscal 2015) — the current reading is the lowest in ten years. Free cash flow has fallen for 6 consecutive fiscal years. Celcuity, Inc. ranks 537th of 603 Biotechnology companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | −$153.5M | — |
| FY2024 | −$83.7M | — |
| FY2023 | −$53.9M | — |
| FY2022 | −$36.2M | — |
| FY2021 | −$20.4M | — |
| FY2020 | −$7.2M | — |
| FY2019 | −$6.4M | — |
| FY2018 | −$6.7M | — |
| FY2017 | −$5.2M | — |
| FY2016 | −$2.9M | — |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Jun 2026 | −$55.6M | — |
| Mar 2026 | −$55.4M | — |
| Dec 2025 | −$36.5M | — |
| Sep 2025 | −$44.9M | — |
| 38 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| TARS Tarsus Pharmaceuticals, Inc. compare | $32.4M |
| TLX Telix Pharmaceuticals Limited compare | −$4.4M |
| ELVN Enliven Therapeutics, Inc. compare | −$67.0M |
| CELC Celcuity, Inc. | −$192.3M |
| VRDN Viridian Therapeutics, Inc. compare | −$343.4M |
| IDYA IDEAYA Biosciences, Inc. compare | −$349.8M |
| DNLI Denali Therapeutics Inc. compare | −$450.0M |
| VKTX Viking Therapeutics, Inc. compare | −$462.6M |
| DYN Dyne Therapeutics, Inc. compare | −$480.4M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)